107 related articles for article (PubMed ID: 11552990)
1. E1A3 as a unique, naturally occurring BCR-ABL transcript in an indolent case of chronic myeloid leukaemia.
Roman J; Jimenez A; Barrios M; Castillejo JA; Maldonado J; Torres A
Br J Haematol; 2001 Sep; 114(3):635-7. PubMed ID: 11552990
[TBL] [Abstract][Full Text] [Related]
2. bcr-abl mRNA lacking abl exon a2 detected by polymerase chain reaction in a chronic myelogeneous leukemia patient.
van der Plas DC; Soekarman D; van Gent AM; Grosveld G; Hagemeijer A
Leukemia; 1991 Jun; 5(6):457-61. PubMed ID: 2056770
[TBL] [Abstract][Full Text] [Related]
3. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
[TBL] [Abstract][Full Text] [Related]
4. Philadelphia chromosome-positive chronic myeloid leukemia expressing p190(BCR-ABL).
Ohsaka A; Shiina S; Kobayashi M; Kudo H; Kawaguchi R
Intern Med; 2002 Dec; 41(12):1183-7. PubMed ID: 12521212
[TBL] [Abstract][Full Text] [Related]
5. The e1a3
Chen Z
Hematology; 2023 Dec; 28(1):2186040. PubMed ID: 36912524
[No Abstract] [Full Text] [Related]
6. A novel BCR-ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia-positive chronic myeloid leukaemia.
Branford S; Rudzki Z; Hughes TP
Br J Haematol; 2000 Jun; 109(3):635-7. PubMed ID: 10886215
[TBL] [Abstract][Full Text] [Related]
7. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
[TBL] [Abstract][Full Text] [Related]
8. P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?
Melo JV; Myint H; Galton DA; Goldman JM
Leukemia; 1994 Jan; 8(1):208-11. PubMed ID: 8289491
[TBL] [Abstract][Full Text] [Related]
9. Are aberrant BCR--ABL transcripts more common than previously thought?
Wilson GA; Vandenberghe EA; Pollitt RC; Rees DC; Goodeve AC; Peake IR; Reilly JT
Br J Haematol; 2000 Dec; 111(4):1109-11. PubMed ID: 11167748
[TBL] [Abstract][Full Text] [Related]
10. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
11. BCR/ABL rearrangement in Philadelphia chromosome negative CML patients.
Rerkamnuaychoke B; Jomsawat U; Maneesri N; Apilugsanachit A; Pattanasak N
J Med Assoc Thai; 2000 Mar; 83 Suppl 1():S70-5. PubMed ID: 10865410
[TBL] [Abstract][Full Text] [Related]
12. Multiplex in-cell reverse transcription-polymerase chain reaction for the simultaneous detection of p210 and p190 BCR-ABL mRNAs in chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia cell lines.
Suh SP; Kee SJ; Lim WH; Song JW; Lee SK; Kim JP; Shin JH; Ryang DW
Clin Chem Lab Med; 2000 Sep; 38(9):939-44. PubMed ID: 11097354
[TBL] [Abstract][Full Text] [Related]
13. Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia.
Lichty BD; Keating A; Callum J; Yee K; Croxford R; Corpus G; Nwachukwu B; Kim P; Guo J; Kamel-Reid S
Br J Haematol; 1998 Dec; 103(3):711-5. PubMed ID: 9858221
[TBL] [Abstract][Full Text] [Related]
14. Typical essential thrombocythaemia does not express bcr-abelson fusion transcript.
Damaj G; Delabesse E; Le Bihan C; Asnafi V; Rachid M; Lefrère F; Radford-Weiss I; Macintyre E; Hermine O; Varet B
Br J Haematol; 2002 Mar; 116(4):812-6. PubMed ID: 11886385
[TBL] [Abstract][Full Text] [Related]
15. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
[TBL] [Abstract][Full Text] [Related]
16. A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical course.
Byrne JL; Carter GI; Davies JM; Haynes AP; Russell NH; Cross NC
Br J Haematol; 1998 Dec; 103(3):791-4. PubMed ID: 9858233
[TBL] [Abstract][Full Text] [Related]
17. [Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene].
Qin YZ; Liu YR; Li JL; Wang H; Chang Y; Fu JY; Ruan GR; Shi HL; Qiu JY; Lu DP; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):409-12. PubMed ID: 15355693
[TBL] [Abstract][Full Text] [Related]
18. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
[TBL] [Abstract][Full Text] [Related]
19. Unusual expression of mRNA typical of Philadelphia positive acute lymphoblastic leukemia detected in chronic myeloid leukemia.
Kirk JA; Radich J; Edmands S; Lee A; VanDevanter DR; Reems JA; Bryant EM
Am J Hematol; 1996 Jul; 52(3):129-34. PubMed ID: 8756076
[TBL] [Abstract][Full Text] [Related]
20. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
Batista DA; Hawkins A; Murphy KM; Griffin CA
Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
